Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt
Radiochemotherapy Including Cisplatin Alone versus Cisplatin + 5-Fluorouracil for Locally Advanced Unresectable Stage IV Squamous Cell Carcinoma of the Head and Neck
โ Scribed by Silke Tribius; Stefanie Kronemann; Yasemin Kilic; Ursula Schroeder; Samer Hakim; Steven E. Schild; Dirk Rades
- Publisher
- Springer
- Year
- 2009
- Tongue
- German
- Weight
- 307 KB
- Volume
- 185
- Category
- Article
- ISSN
- 0179-7158
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi
## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat